RE: Big pharma14 Feb 2021 13:25
For me its always a case of first mover has the advantage. I suspect that most will be waiting to see the Phase 3 results after all no CEO wants to spend billions on a failure. However these are desperate times and surely rumours are rife that this is a winning treatment? SO I expect a pharma to jump the gun and pounce before the final results. If so I guess they will be talking to a lot of ii's linked to SNG to bring them onboard?